# Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG Parameters

> **NCT00903747** · PHASE1 · COMPLETED · sponsor: **Movetis** · enrollment: 120 (actual)

## Conditions studied

- Constipation

## Interventions

- **DRUG:** prucalopride
- **DRUG:** moxifloxacin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00903747
- **Lead sponsor:** Movetis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2009-04
- **Final completion:** 2009-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2009-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00903747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00903747, "Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG Parameters". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00903747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*